NASDAQ:AVXL
$11.26
(
-0.97%
)
Friday, 3rd Feb 2023
Anavex Life Sciences Corp. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $9.46 | $11.71 | Friday, 3rd Feb 2023 AVXL stock ended at $11.26. This is 0.97% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 4.89% from a day low at $11.05 to a day high of $11.59. |
| 90 days | $7.63 | $15.24 | |
| 52 weeks | $7.13 | $15.24 |
Historical Anavex Life Sciences Corp. prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $11.11 | $11.59 | $11.05 | $11.26 | 1 069 259 |
| 2023-02-02 | $11.09 | $11.71 | $10.97 | $11.37 | 1 430 566 |
| 2023-02-01 | $10.89 | $11.22 | $10.57 | $10.99 | 1 170 949 |
| 2023-01-31 | $10.13 | $10.89 | $10.06 | $10.87 | 1 369 166 |
| 2023-01-30 | $10.74 | $10.76 | $9.84 | $10.05 | 1 922 059 |
| 2023-01-27 | $10.52 | $10.69 | $10.41 | $10.56 | 601 500 |
| 2023-01-26 | $10.91 | $10.99 | $10.39 | $10.52 | 594 548 |
| 2023-01-25 | $10.52 | $10.83 | $10.32 | $10.79 | 871 783 |
| 2023-01-24 | $10.38 | $10.91 | $10.22 | $10.72 | 1 154 251 |
| 2023-01-23 | $10.33 | $10.58 | $10.13 | $10.47 | 970 684 |
| 2023-01-20 | $10.22 | $10.41 | $9.98 | $10.30 | 981 763 |
| 2023-01-19 | $9.99 | $10.24 | $9.65 | $10.10 | 1 116 600 |
| 2023-01-18 | $10.56 | $10.75 | $10.06 | $10.13 | 1 206 547 |
| 2023-01-17 | $10.50 | $10.63 | $10.21 | $10.46 | 1 621 981 |
| 2023-01-13 | $11.05 | $11.34 | $10.15 | $10.58 | 2 105 408 |
| 2023-01-12 | $10.86 | $11.24 | $10.38 | $11.21 | 1 923 905 |
| 2023-01-11 | $10.39 | $10.82 | $10.10 | $10.80 | 1 483 107 |
| 2023-01-10 | $9.83 | $10.39 | $9.78 | $10.39 | 1 170 341 |
| 2023-01-09 | $10.14 | $10.17 | $9.57 | $9.85 | 1 121 519 |
| 2023-01-06 | $10.02 | $10.20 | $9.68 | $10.00 | 1 543 800 |
| 2023-01-05 | $9.91 | $9.97 | $9.46 | $9.87 | 1 062 077 |
| 2023-01-04 | $9.74 | $10.09 | $9.46 | $9.97 | 1 351 582 |
| 2023-01-03 | $9.89 | $9.89 | $9.32 | $9.68 | 1 759 063 |
| 2022-12-30 | $9.00 | $9.26 | $8.91 | $9.26 | 1 080 798 |
| 2022-12-29 | $8.29 | $9.28 | $8.20 | $9.13 | 1 852 252 |
| 2022-12-28 | $8.11 | $8.34 | $8.01 | $8.19 | 1 007 153 |
| 2022-12-27 | $8.45 | $8.55 | $8.13 | $8.16 | 1 196 164 |
| 2022-12-23 | $8.60 | $8.69 | $8.22 | $8.45 | 850 312 |
| 2022-12-22 | $8.60 | $8.69 | $8.28 | $8.57 | 1 204 159 |
| 2022-12-21 | $8.68 | $8.86 | $8.44 | $8.61 | 1 171 623 |
| 2022-12-20 | $8.47 | $8.91 | $8.36 | $8.71 | 1 094 310 |
| 2022-12-19 | $8.65 | $8.69 | $8.18 | $8.51 | 1 634 836 |
| 2022-12-16 | $8.27 | $8.70 | $8.19 | $8.64 | 3 155 206 |
| 2022-12-15 | $8.70 | $8.80 | $8.30 | $8.35 | 1 537 386 |
| 2022-12-14 | $8.68 | $8.98 | $8.50 | $8.83 | 1 319 980 |
| 2022-12-13 | $8.94 | $9.05 | $8.37 | $8.74 | 1 780 898 |
| 2022-12-12 | $7.75 | $8.85 | $7.73 | $8.67 | 3 394 869 |
| 2022-12-09 | $7.99 | $8.07 | $7.63 | $7.65 | 2 292 232 |
| 2022-12-08 | $8.50 | $8.52 | $7.95 | $8.08 | 2 635 981 |
| 2022-12-07 | $8.34 | $9.10 | $8.31 | $8.49 | 2 737 453 |
| 2022-12-06 | $9.21 | $9.21 | $8.34 | $8.38 | 6 006 781 |
| 2022-12-05 | $12.03 | $12.11 | $9.56 | $9.58 | 8 403 482 |
| 2022-12-02 | $12.57 | $13.23 | $10.66 | $12.05 | 45 682 568 |
| 2022-12-01 | $8.90 | $9.57 | $8.80 | $8.87 | 2 157 524 |
| 2022-11-30 | $8.96 | $9.14 | $8.29 | $8.82 | 4 017 257 |
| 2022-11-29 | $9.24 | $9.46 | $8.77 | $8.94 | 2 155 419 |
| 2022-11-28 | $12.46 | $12.49 | $8.87 | $9.10 | 4 351 921 |
| 2022-11-25 | $11.30 | $11.95 | $11.25 | $11.89 | 778 695 |
| 2022-11-23 | $11.72 | $11.86 | $11.09 | $11.36 | 958 169 |
| 2022-11-22 | $11.80 | $11.80 | $10.97 | $11.42 | 1 052 751 |
About Anavex Life Sciences Corp.
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
